Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:METX)

2.800 UNCHANGED
Delayed Quote Updated: 2:14 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.800
Bid (Size) 1.600 (1,000)
Ask (Size) 2.750 (200)
Prev. Close 2.800
Today's Range 2.800 - 2.800
52wk Range 1.500 - 8.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
From ME Therapeutics Holdings Inc.
Via Business Wire

Performance

52-Week Range 65.0% below 52-week high
2.800
1.5052W Low 8.0052W High
1 Week
1.601W Low 2.801W High

(METX) traded between $1.50 and $8.00 over the past 52 weeks and last traded at $2.80, 65.0% below its 52-week high. Over the past week it ranged between $1.60 and $2.80.

Past 12 Months
+40.0%
+75.0%
-4.8%
-5.1%
-22.0%
-58.8%
1W +$0.80
1M +$1.20
3M -$0.14
6M -$0.15
YTD -$0.79
1Y -$4.00

METX was -58.8% over the past year, -5.1% over six months, -22.0% year to date, +40.0% in the last week.

12 Months vs Market
METX
-58.8%
DIA
+12.0%
SPY
+17.4%
QQQ
+24.8%
IWM
+14.1%

Over the past 12 months METX returned -58.8% versus DIA (Dow) +12.0%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +24.8% and IWM (Russell 2000) +14.1%.

Volume & Liquidity
1W
700.0
1M
844.0
3M
1.1K
6M
820.0
YTD
677.0
1Y
770.0

METX's 3-month average daily volume is 1.1K.

More News

Read More
News headline image
ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Scientific and Corporate Update
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Attending JP Morgan Healthcare Conference
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Added to CSE25 Index
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
News headline image
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
From ME Therapeutics Holdings Inc.
Via Business Wire

Frequently Asked Questions

Is METX publicly traded?
Yes, METX is publicly traded.
What exchange does METX trade on?
METX trades on the Canadian Securities Exchange
What is the ticker symbol for METX?
The ticker symbol for METX is METX on the Canadian Securities Exchange
What is the current price of METX?
The current price of METX is 2.800
When was METX last traded?
The last trade of METX was at 10/08/26 02:14 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.